menu search

HROW / Harrow Health Transaction Moves It Closer To The Big Leagues For 2023

Harrow Health Transaction Moves It Closer To The Big Leagues For 2023
Harrow Health is a founder-led eyecare company, the CEO holds 10% of the shares. It is moving up the value chain with a focus on branded products such as a recent (second) deal with Novartis. Read More
Posted: Dec 15 2022, 04:47
Author Name: Seeking Alpha
Views: 111592

HROW News  

Harrow Health's 5-Year Guidance

By Seeking Alpha
September 27, 2023

Harrow Health's 5-Year Guidance

Harrow Health has guided to at least $1 billion in revenue by 2027 based on their current portfolio of drugs. The company's deep moat and strong custo more_horizontal

Harrow Health, Inc. (HROW) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 9, 2023

Harrow Health, Inc. (HROW) Q2 2023 Earnings Call Transcript

Harrow Health, Inc. (NASDAQ:HROW ) Q2 2023 Earnings Conference Call August 9, 2023 4:45 PM ET Company Participants Jamie Webb - Director-Communication more_horizontal

Harrow Health And Its Interesting 11.6% 2027 Baby Bond

By Seeking Alpha
August 1, 2023

Harrow Health And Its Interesting 11.6% 2027 Baby Bond

Harrow Health is an eye care pharmaceuticals company. The common stock has been on fire with expectations of rapidly increasing profits. HROW has 2 ba more_horizontal

Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?

By Zacks Investment Research
July 20, 2023

Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?

Harrow (HROW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the st more_horizontal

Why Shares of Harrow Health Are Jumping Wednesday

By The Motley Fool
July 19, 2023

Why Shares of Harrow Health Are Jumping Wednesday

Harrow added seven new products through an acquisition. The company said it expects increased revenue year over year in the second quarter. more_horizontal

Harrow Health (HROW) Flat As Market Sinks: What You Should Know

By Zacks Investment Research
June 23, 2023

Harrow Health (HROW) Flat As Market Sinks: What You Should Know

Harrow Health (HROW) closed at $18.52 in the latest trading session, marking no change from the prior day. more_horizontal

Harrow Health: Mostly Good, Some Bad

By Seeking Alpha
June 12, 2023

Harrow Health: Mostly Good, Some Bad

Harrow Healthcare is well-positioned to grow in the US Ophthalmology market, with a branded pharma sales strategy that could boost growth and margins. more_horizontal

Why Shares of Harrow Health Are Slumping Friday

By The Motley Fool
May 12, 2023

Why Shares of Harrow Health Are Slumping Friday

Harrow had a $6.6 million loss in the first quarter. It just launched its latest therapy, the ocular anesthesia Iheeza. more_horizontal


Search within

Pages Search Results: